Last year, the Bakers made a significant bet on ACADIA Pharma (ACAD) when the stock was selling for under $2 per share. On November 27th, 2012, the company reported positive data results for its drug pimavanserin, which is designed to treat Parkinson's disease psychosis (PDP). The news prompted a huge rally in the stock that has mostly continued to this day. Since PDP is a serious unmet need, the speculation continues to swell around ACADIA, and eventual FDA approval which could come in 2015 would further rally the stock, perhaps even 100% or higher from its current level.
The Baker Brothers are up well over 2500% in Acadia since their initial investment.
Baker Brothers Advisors, LLC 20,481,442 20.69 498,313,483 Mar 31, 2014
BAKER BROTHERS LIFE SCIENCES LP 14,229,612 Jan 18, 2013
It's been speculated all day on ihub that it's the Baker Bros. If so, this supposed "negative" will turn into an incredible positive catalyst. I've been hoping all day that's what we find out early next week.